EG21717A - Process for preparing of 4-oxo naphyri - dine -3- caboxamides gaba brain receptor ligands - Google Patents

Process for preparing of 4-oxo naphyri - dine -3- caboxamides gaba brain receptor ligands

Info

Publication number
EG21717A
EG21717A EG118098A EG118098A EG21717A EG 21717 A EG21717 A EG 21717A EG 118098 A EG118098 A EG 118098A EG 118098 A EG118098 A EG 118098A EG 21717 A EG21717 A EG 21717A
Authority
EG
Egypt
Prior art keywords
naphyri
caboxamides
dine
oxo
preparing
Prior art date
Application number
EG118098A
Other languages
English (en)
Inventor
Pamela Albaugh
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of EG21717A publication Critical patent/EG21717A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EG118098A 1997-08-25 1998-09-29 Process for preparing of 4-oxo naphyri - dine -3- caboxamides gaba brain receptor ligands EG21717A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
EG21717A true EG21717A (en) 2002-02-27

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
EG118098A EG21717A (en) 1997-08-25 1998-09-29 Process for preparing of 4-oxo naphyri - dine -3- caboxamides gaba brain receptor ligands

Country Status (24)

Country Link
EP (1) EP1007526A1 (https=)
JP (1) JP2001514181A (https=)
KR (1) KR20010023313A (https=)
CN (1) CN1268136A (https=)
AP (1) AP2000001742A0 (https=)
AU (1) AU753800B2 (https=)
BG (1) BG104192A (https=)
BR (1) BR9811362A (https=)
CA (1) CA2301599C (https=)
EG (1) EG21717A (https=)
HU (1) HUP0003258A3 (https=)
IL (1) IL134291A0 (https=)
IS (1) IS5382A (https=)
LV (1) LV12539B (https=)
NO (1) NO20000822L (https=)
NZ (1) NZ502548A (https=)
OA (1) OA11293A (https=)
PE (1) PE130999A1 (https=)
PL (1) PL338783A1 (https=)
SI (1) SI20270A (https=)
SK (1) SK2162000A3 (https=)
TW (1) TW574221B (https=)
WO (1) WO1999010347A1 (https=)
YU (1) YU10500A (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60018274T2 (de) * 1999-05-06 2005-08-04 Neurogen Corp., Branford Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
WO2000071528A1 (en) * 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
EP1326611B1 (en) 2000-10-12 2007-06-13 Merck & Co., Inc. Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
ATE345129T1 (de) 2000-10-12 2006-12-15 Merck & Co Inc Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
PL360944A1 (en) 2000-10-12 2004-09-20 Merck & Co, Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
CZ20032338A3 (cs) * 2001-03-01 2004-08-18 Pfizeráproductsáinc Použití inversních agonistů GABA A v kombinaci s parciálními agonisty receptoru nikotinuŹ estrogenemŹ selektivními modulátory estrogenu nebo vitaminem E při léčení kognitivních poruch
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
EP1467970B1 (en) 2002-01-17 2007-08-22 Merck & Co., Inc. Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
ATE409187T1 (de) 2002-03-15 2008-10-15 Merck & Co Inc N-(substituierte benzyl)-8-hydroxy-1,6- naphthyridin-7- carbonsäureamide als hiv- integrase-hemmer
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
NZ576036A (en) * 2006-10-16 2010-10-29 Bionomics Ltd Naphthyridine containing compounds for treating anxiety disorders
PL2083811T3 (pl) * 2006-11-22 2017-05-31 Clinical Research Associates, Llc Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204813A1 (es) * 1972-05-08 1976-03-05 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampilicina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
KR20010023313A (ko) 2001-03-26
IL134291A0 (en) 2001-04-30
IS5382A (is) 2000-02-22
SI20270A (sl) 2000-12-31
SK2162000A3 (en) 2001-03-12
NO20000822L (no) 2000-04-13
CA2301599C (en) 2003-03-25
CN1268136A (zh) 2000-09-27
AP2000001742A0 (en) 2000-02-24
LV12539A (en) 2000-10-20
TW574221B (en) 2004-02-01
AU753800B2 (en) 2002-10-31
HUP0003258A2 (en) 2001-03-28
NO20000822D0 (no) 2000-02-18
NZ502548A (en) 2002-06-28
BR9811362A (pt) 2000-08-22
HUP0003258A3 (en) 2001-05-28
JP2001514181A (ja) 2001-09-11
OA11293A (en) 2002-11-19
CA2301599A1 (en) 1999-03-04
PE130999A1 (es) 1999-12-16
YU10500A (sh) 2002-10-18
EP1007526A1 (en) 2000-06-14
PL338783A1 (en) 2000-11-20
BG104192A (en) 2001-05-31
WO1999010347A1 (en) 1999-03-04
LV12539B (en) 2001-01-20
AU9117398A (en) 1999-03-16

Similar Documents

Publication Publication Date Title
EG21717A (en) Process for preparing of 4-oxo naphyri - dine -3- caboxamides gaba brain receptor ligands
IL125391A0 (en) Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands
ZA976244B (en) Certain fused pyrrolecarboxanilides a new class of gaba brain receptor ligands
CZ252597A3 (cs) Způsob výroby azacyklohexapeptidů
AU2218997A (en) Certain fused pyrrolecarboxamides as gaba brain receptor ligands
HUP9900318A3 (en) Process for preparing 4-aryl-piperidine derivatives
EG22337A (en) Process for preparing novel pharmaceutical compounds
SG70081A1 (en) Process for producing diamines
HUP9901339A3 (en) Process for producing n-substituted 3-hydroxypyrazoles
IL147971A0 (en) Fused pyrrolecarboxamides: gaba brain receptor ligands
HUP9600321A1 (en) Process for preparation of n-substituted cyclic-imide-derivatives
IL134059A0 (en) Process for preparing aminoarylacetylenes
IL118992A (en) Process for preparing norbenzomorphan derivatives
IL131205A0 (en) Process for preparing pharmaceutical compounds
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
HUP0003069A3 (en) Process for preparing amides
IL126184A0 (en) Process for preparing pentafluoropentanol
HUP9802495A3 (en) Process for producing of formyl-imidazole-derivatives
IL123561A0 (en) Process for preparing dioxoazabicyclohexanes
AP2000001781A0 (en) Process for preparation of azacycloalkylalkanoyl pseudotetrapeptides
EG21226A (en) Process for preparing of new pharmaceutical compound
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
HUP9802646A3 (en) Process for producing formylimidazol derivatives
KR100641508B1 (en) Improved process for the preparation of phosphites
GB9810502D0 (en) Process for preparing distrylbiphenyl compounds